0001681820-16-000002.txt : 20160811 0001681820-16-000002.hdr.sgml : 20160811 20160810174029 ACCESSION NUMBER: 0001681820-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160811 DATE AS OF CHANGE: 20160810 EFFECTIVENESS DATE: 20160811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DMD Therapeutics Inc. CENTRAL INDEX KEY: 0001681820 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-268698 FILM NUMBER: 161822377 BUSINESS ADDRESS: STREET 1: P.O. BOX 1597 CITY: MERCER ISLAND STATE: WA ZIP: 98040 BUSINESS PHONE: 2064528700 MAIL ADDRESS: STREET 1: P.O. BOX 1597 CITY: MERCER ISLAND STATE: WA ZIP: 98040 D 1 primary_doc.xml X0707 D LIVE 0001681820 DMD Therapeutics Inc. 2032 41st Avenue E Seattle WA WASHINGTON 98112 2067901094 DELAWARE None None Corporation true 2015 Ronald Berenson 2032 41st Avenue E Seattle WA WASHINGTON 98112 Executive Officer Director Promoter Other Decline to Disclose 06b false 2016-07-26 false true Investment contract false 100000 600000 0 600000 false 3 0 0 0 false DMD Therapeutics Inc. /s/ Ronald J. Berenson Ronald J. Berenson President 2016-08-10